Department of Radiology, Kurume University School of Medicine.
Department of Radiology, Kyoto Prefectural University of Medicine.
Kurume Med J. 2022 Mar 11;67(1):41-47. doi: 10.2739/kurumemedj.MS671003. Epub 2021 Nov 26.
Radiation-induced olfactory neuroblastoma (ONB) is an uncommon neoplasm that is generally associated with a poor prognosis. We experienced an unusual case of ONB in a patient who had received previous radiation therapy for extranodal NK/T-cell lymphoma 15 years previously. To our knowledge, this is the first report of a patient with radiation-induced ONB obtaining a complete response (CR) with radical re-irradiation alone. The purpose of this report is to discuss therapeutic strategies for radiation-induced ONB. We report an unusual case of ONB suspected to be a radiation-induced neoplasm in a 33-year-old female who had received 30 Gy of irradiation for extranodal NK/T-cell lymphoma, nasal type (NTCL) 15 years earlier. In this case, the patient presented with nasal obstruction and frequent epistaxis. The patient was diagnosed with ONB based on left nasal biopsy findings. The surrounding normal tissues tolerance of nasal ONB radiation had to be limited, because the previously radiated NTCL was located adjacent to critical organs. We performed intensity modulated radiation therapy (IMRT), which could offer precise irradiation (60 Gy in 2 Gy daily fractions) while sparing critical tissues. The present case was treated with radiation therapy alone, whereas previously reported cases were treated with a combination of chemotherapy and radiation therapy. We treated radiation-induced OBN successfully with radical re-irradiation using IMRT alone and the patient has had no recurrence for 3 years.
放射诱导性嗅神经母细胞瘤(ONB)是一种不常见的肿瘤,通常预后不良。我们遇到了一例 15 年前因结外 NK/T 细胞淋巴瘤接受过放射治疗的患者发生的不典型 ONB 病例。据我们所知,这是首例单独接受根治性再放射治疗即可获得完全缓解(CR)的放射诱导性 ONB 患者的报告。本报告旨在讨论放射诱导性 ONB 的治疗策略。我们报告了一例不典型的嗅神经母细胞瘤病例,该患者为 33 岁女性,15 年前因鼻型结外 NK/T 细胞淋巴瘤(NTCL)接受了 30 Gy 的照射。在该病例中,患者出现了鼻塞和频繁鼻出血。根据左鼻腔活检结果诊断为嗅神经母细胞瘤。由于先前放射治疗的 NTCL 紧邻重要器官,因此必须限制鼻腔 ONB 放射对周围正常组织的耐受性。我们采用了调强放射治疗(IMRT),可以在保护关键组织的同时提供精确的照射(2 Gy 每日剂量 60 Gy)。本例仅接受放射治疗,而先前报道的病例则接受了化疗和放射治疗的联合治疗。我们成功地使用 IMRT 单独进行根治性再放射治疗来治疗放射诱导性 OBN,并且患者在 3 年内没有复发。